Research Progress of Alternative Polyadenylation in Diseases Related to Glycolipid Metabolism

Xiyao Yang,Alayi Bolatai,Jiaxin An,Na Wu
DOI: https://doi.org/10.2147/dmso.s470647
2024-11-20
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Xiyao Yang, 1, &ast Alayi Bolatai, 2, &ast Jiaxin An, 2 Na Wu 1, 3 1 Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, 110004, People' s Republic of China; 2 Department of Student Affairs, Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, People' s Republic of China; 3 Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, People' s Republic of China &astThese authors contributed equally to this work Correspondence: Na Wu, Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, People' s Republic of China, Email With changes in lifestyle, sedentary behavior or lack of physical exercise increases the risk of various glycolipid metabolic disorders. Glycolipid metabolic dysregulation refers to abnormalities in the metabolism of carbohydrates and lipids, including diseases such as diabetes, obesity, and metabolic syndrome. In-depth research into the molecular mechanisms of glycolipid metabolic dysregulation can help develop more effective treatment strategies and preventive measures to prevent the occurrence of long-term complications such as cardiovascular diseases. Alternative polyadenylation (APA) is an important form of RNA modification that helps regulate gene expression and generate protein diversity. This modification can affect processes such as RNA stability, post-transcriptional modification, and translational regulation. Recent studies have confirmed that APA can influence the expression of genes involved in glucose and lipid metabolism, increasing the probability of developing immune, endocrine, and metabolic diseases. The review explains the research progress of APA involvement in various metabolic diseases and explores these mechanisms, providing new insights and directions for novel metabolic disorder treatment strategies. Keywords: APA, alternative polyadenylation, glycolipid metabolic diseases, 3'UTRs, diabetes, obesity, metabolism, dysfunction Alternative polyadenylation (APA), a prevalent phenomenon in eukaryotes, aids in regulating gene expression and generating protein diversity. It is estimated that 30% to 70% of genes produce mRNA isoforms with multiple optional 3' Untranslated Regions (3'UTRs). 1 APA plays a critical role in development, and its misregulation is associated with various human diseases, including cancer. 2 APA is mainly divided into two types: 3'UTR APA and intronic APA (IPA). 3'UTR-APA mainly affects the stability of mRNA, translation efficiency, nuclear output and cell localization, while IPA may lead to the change of coding sequence, thus affecting the function and stability of protein. 3 The APA modification of mRNA has emerged as a crucial mechanism in post-transcriptional gene regulation in higher eukaryotes, wherein processes involving poly(A) influence translation, mRNA stability, nuclear export, and play significant roles in various physiological and pathological processes 4 . With changes in lifestyle, prolonged sedentary behavior or lack of physical exercise increases the risk of various metabolic disorders, such as type 2 diabetes, obesity, cardiovascular diseases, non-alcoholic fatty liver disease, high cholesterol levels, and others. Additionally, there is a growing trend towards younger onset of these conditions, posing a serious threat to human health. 5 Timely treatment of metabolic pathway dysregulation may improve the development of metabolic-related diseases such as diabetes and obesity, 6 If the above-mentioned diseases are not treated properly, they may lead to various chronic complications throughout the body. 7 APA dysregulation is associated with various metabolic pathways, with the most extensively studied being abnormalities in carbohydrate and lipid metabolism. Research indicates that APA serves as a pathogenic factor in multiple diseases, including neonatal diabetes, type 1 diabetes, type 2 diabetes, and preeclampsia. 8,9 Additionally, APA can influence the expression of genes involved in glucose and lipid metabolism, thereby increasing the likelihood of immune, endocrine, and metabolic diseases. 10 This discovery suggests that APA may potentially alter metabolic homeostasis through modifications to metabolism-related genes, thereby playing a role in disease progression. The relationship between alternative polyadenylation and metabolic dysregulation is an active area of research, with studies steadily increasing in recent years (see Figure 1). However, the mechanisms underlying APA involvement in metabolic-related diseases still require further investigation for clarification. Exploring these -Abstract Truncated-
endocrinology & metabolism
What problem does this paper attempt to address?